Assembly votes to let court decide on opposition chief’s arrest warrant
[Today’s K-pop] Blackpink’s Rose only one to renew with label: report
Parliament passes arrest motion against opposition leader, dismissal motion against PM
Opposition head pleads for support in ‘fight against Yoon dictatorship’
[News Focus] What are the implications of Yoon naming Russia before NK?
Koreans prefer cash in Chuseok gifting for parents
Broadcom slapped with W19.1b fine for abusing market power in Korea
Seoul plans to modernize Dongseoul Bus Terminal
Apple to launch iPhone15 series in S. Korea on Oct. 13
[Well-curated] A weekend for fall-time festivities
SK chairman discusses global health commitments with GatesBy Kan Hyeong-woo
Published : Aug. 16, 2022 - 17:49
According to officials, SK Discovery Executive Vice Chairman Chey Chang-won and SK Bioscience CEO Ahn Jae-yong also attended the meeting in Yeouido, western Seoul. The SK leaders and Gates talked about how they can cooperate to improve global health.
SK Bioscience said the company and the Bill and Melinda Gates Foundation have agreed to keep exploring methods to solve the global health problem and continue research and development efforts for new treatments and vaccines to respond to the next pandemic.
SK Bioscience has partnered with the Bill and Melinda Gates Foundation since 2013. The foundation provided funding for the South Korean vaccine developer’s efforts to create a number of products including a typhoid vaccine and nonreplicating rotavirus vaccine.
SK Bioscience received $3.6 million from the foundation to develop SKYCovieone, the country’s first domestic COVID-19 vaccine. With the funding, the company is also currently developing an antiviral nasal spray to prevent COVID-19 infections.
U.S. finalizes national security 'guardrails' for CHIPS funding
Opposition party leader ends 24-day hunger strike for treatment
PM arrives in China for Asian Games, meeting with Xi